NCNA net incomeFY2025-£29.35M
NCNA net income was -£29.35M for fiscal 2025 (ended Dec 31, 2025), compared with -£19.00M in fiscal 2024.
NuCana plc (NCNA) financials
For fiscal 2025 (ended Dec 31, 2025), NuCana plc reported -£29.35M of net income. Figures are in GBP, the currency of its SEC filings.
- Net income, FY2025
- -£29.35M
- Free cash flow, FY2025
- -£7.47M
- EPS, diluted, FY2025
- £0.00
- Cash
- £24.25M
FY2016FY2025
FY2016FY2025
NCNA revenue and earnings growth
NCNA EPSFY2025£0.00
NCNA diluted EPS was £0.00 for fiscal 2025 (ended Dec 31, 2025).
NCNA free cash flowFY2025-£7.47M
NCNA free cash flow was -£7.47M for fiscal 2025 (ended Dec 31, 2025), compared with -£19.12M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | £12.74M | £18.02M | £25.06M | £36.43M | £36.83M | £25.90M | £19.73M | £16.85M | £17.67M | £7.90M |
| Selling, general and admin | £8.10M | £4.99M | £6.06M | £7.29M | £8.53M | £7.05M | £5.95M | £5.18M | £4.57M | £1.14M |
| Operating income | -£20.11M | -£22.81M | -£32.78M | -£39.12M | -£47.91M | -£36.42M | -£26.70M | -£19.13M | -£25.69M | -£8.45M |
| Interest expense | £12.65M | £0 | £0 | - | - | - | - | - | £1.79M | - |
| Pre-tax income | -£30.52M | -£22.45M | -£32.03M | -£38.45M | -£47.80M | -£36.17M | -£25.65M | -£18.06M | -£25.49M | -£8.16M |
| Income tax | -£1.17M | -£3.45M | -£4.40M | -£6.43M | -£7.27M | -£5.49M | -£4.24M | -£4.22M | -£2.40M | -£2.12M |
| Net income | -£29.35M | -£19.00M | -£27.63M | -£32.02M | -£40.53M | -£30.68M | -£21.41M | -£13.84M | -£23.09M | -£6.05M |
| EPS, basic | £0.00 | -£0.26 | -£0.53 | -£0.61 | -£0.78 | - | - | - | - | - |
| EPS, diluted | £0.00 | -£0.26 | -£0.53 | -£0.61 | -£0.78 | - | - | - | - | - |
| Diluted shares | 11.23B | 74.2M | 52.6M | 52.2M | 52.0M | 37.9M | 32.3M | 32.0M | 26.1M | 24.1M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | £24.25M | £6.75M | £17.23M | £41.91M | £60.26M | £87.36M | £51.96M | £76.97M | £86.70M | £19.99M |
| Receivables | £849.0K | £922.0K | £2.67M | £3.96M | £4.16M | £4.63M | £4.71M | £2.35M | £3.05M | - |
| Current assets | £26.86M | £12.27M | £25.02M | £54.92M | £71.61M | £101.81M | £65.15M | £83.59M | £93.98M | £25.82M |
| Total assets | £29.83M | £14.77M | £27.81M | £58.25M | £77.47M | £107.79M | £70.27M | £87.19M | £96.36M | £27.21M |
| Current liabilities | £4.79M | £8.67M | £12.68M | £19.31M | £11.72M | £8.15M | £6.18M | £5.57M | £2.92M | £1.97M |
| Total liabilities | £5.51M | £8.82M | £12.92M | £19.75M | £11.93M | £8.56M | £6.75M | £5.59M | £2.94M | £1.97M |
| Shareholders' equity | £24.33M | £5.95M | £14.89M | £38.50M | £65.55M | £99.23M | £63.52M | £81.59M | £93.42M | £25.24M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -£7.47M | -£19.12M | -£26.44M | -£23.16M | -£23.82M | -£21.62M | -£23.83M | -£12.22M | -£8.71M | -£9.26M |
| Capital expenditures | £0 | £4.0K | £4.0K | £12.0K | £64.0K | £361.0K | £46.0K | £210.0K | £370.0K | £15.0K |
| Free cash flow | -£7.47M | -£19.12M | -£26.44M | -£23.17M | -£23.89M | -£21.98M | -£23.88M | -£12.43M | -£9.08M | -£9.28M |
| Investing cash flow | £159.0K | £79.0K | £2.89M | £120.0K | -£3.56M | -£1.31M | -£145.0K | -£651.0K | -£933.0K | £14.93M |
| Financing cash flow | £25.01M | £8.18M | -£53.0K | -£161.0K | -£98.0K | £61.80M | -£47.0K | £207.0K | £77.75M | £200.0K |
| Stock-based compensation | £10.03M | £1.65M | £3.86M | £4.89M | £6.66M | £4.30M | £3.23M | £1.79M | £11.73M | £1.13M |
| Depreciation and amortization | £274.0K | £522.0K | £575.0K | £732.0K | £942.0K | £890.0K | £718.0K | £371.0K | £194.0K | £101.0K |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on equity | -120.7% | -319.1% | -185.6% | -83.2% | -61.8% | -30.9% | -33.7% | -17.0% | -24.7% | -24.0% |
| Return on assets | -98.4% | -128.6% | -99.4% | -55.0% | -52.3% | -28.5% | -30.5% | -15.9% | -24.0% | -22.2% |
| Current ratio | 5.60 | 1.42 | 1.97 | 2.84 | 6.11 | 12.49 | 10.54 | 15.02 | 32.22 | 13.09 |
Source: XBRL data NuCana plc files with the SEC, latest filing dated Mar 19, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
NCNA peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| NCNA | - | - | -£29.35M | - | $3.9M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.35T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $675.92B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $519.48B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $364.98B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $311.52B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $289.61B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.31B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $180.22B |
NCNA FAQ
6 questionsIs NCNA profitable?
No. NuCana plc reported a net loss of £29.35M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does NCNA have?
NuCana plc reported £24.25M in cash and cash equivalents on its most recent balance sheet in SEC filings.What is NCNA free cash flow?
NuCana plc generated -£7.47M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -£7.47M less capital expenditures.What is NCNA earnings per share?
Diluted earnings per share were £0.00 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did NCNA last report financial results?
The latest statements here come from NuCana plc's 20-F filed on Mar 19, 2026, covering the period ended Dec 31, 2025.Where does this NCNA financial data come from?
Quantisnow builds these statements from the structured XBRL data NuCana plc files with the SEC. It is provided for information only and is not investment advice.